Written by a multidisciplinary panel and led by Prof. Anne-Pascale Meert together with Dr. Maxime Ilzkovitz and Dr. Louis Wolff, this supplement outlines recommendations for the early detection and management of side effects associated with anti-cancer immunotherapies.